Monthly
US$200
Billed every month
Brexpiprazole Tablets(布瑞哌唑片)
Companies, stages and changes, with each record available on this page.
Last 90 days: Marketing application approved: 2 applicationsAccepted: 6 applicationsNo longer listed under review: 3 applications
Current coverage may be incomplete
Which companies are listed, and at what stages?
Each source is counted separately. Expand a list to inspect companies, identifiers, dates and sources.
Company names, approval identifiers and strengths are retained as recorded in the Chinese sources. Category labels include the original wording for verification.
Catalogue holders26View records ↓
Under-review filings31View records ↓
This year’s generic filers5View records ↓
NHSA approval numbers56View records ↓
API companies with A status30View records ↓
Chemical-drug catalogue
Loaded records: 26 holders; 0 in the quality-and-efficacy consistency-evaluation category, and 25 in the new chemical-registration-classification generic category. Category counts may overlap.
| Marketing authorization holder | Manufacturer | Approval number | Approved | Strength / specification | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| 上海现代制药股份有限公司 | 上海现代制药股份有限公司 | 国药准字H20265770 | 2026/08/25 | 2mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 重庆圣华曦药业股份有限公司 | 重庆圣华曦药业股份有限公司 | 国药准字H20265684 | 2026/08/18 | 1mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 重庆圣华曦药业股份有限公司 | 重庆圣华曦药业股份有限公司 | 国药准字H20265683 | 2026/08/18 | 2mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 山东鲁抗医药股份有限公司 | 山东鲁抗医药股份有限公司 | 国药准字H20265542 | 2026/08/04 | 1mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 山东鲁抗医药股份有限公司 | 山东鲁抗医药股份有限公司 | 国药准字H20265541 | 2026/08/04 | 2mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 山东鲁抗医药股份有限公司 | 山东鲁抗医药股份有限公司 | 国药准字H20265543 | 2026/08/04 | 0.25mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 北京仁众药业有限公司 | 沂南力诺制药有限责任公司 | 国药准字H20265617 | 2026/08/04 | 2mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 江苏康缘药业股份有限公司 | 江苏康缘药业股份有限公司 | 国药准字H20265534 | 2026/08/04 | 0.5mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 江苏康缘药业股份有限公司 | 江苏康缘药业股份有限公司 | 国药准字H20265536 | 2026/08/04 | 2mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 江苏康缘药业股份有限公司 | 江苏康缘药业股份有限公司 | 国药准字H20265535 | 2026/08/04 | 1mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 山东京卫制药有限公司 | 山东京卫制药有限公司 | 国药准字H20265368 | 2026/07/28 | 0.5mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 海南广升誉制药有限公司 | 华益泰康药业股份有限公司 | 国药准字H20265396 | 2026/07/28 | 2mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 山东京卫制药有限公司 | 山东京卫制药有限公司 | 国药准字H20265367 | 2026/07/28 | 1mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 山东京卫制药有限公司 | 山东京卫制药有限公司 | 国药准字H20265366 | 2026/07/28 | 2mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 宜昌人福药业有限责任公司 | 宜昌人福药业有限责任公司 | 国药准字H20265402 | 2026/07/28 | 0.5mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 江苏飞马药业有限公司 | 江苏飞马药业有限公司 | 国药准字H20265321 | 2026/07/21 | 2mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 安徽泰恩康制药有限公司 | 安徽泰恩康制药有限公司 | 国药准字H20265239 | 2026/07/21 | 2mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 安徽泰恩康制药有限公司 | 安徽泰恩康制药有限公司 | 国药准字H20265237 | 2026/07/21 | 0.5mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 安徽泰恩康制药有限公司 | 安徽泰恩康制药有限公司 | 国药准字H20265238 | 2026/07/21 | 1mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 江苏飞马药业有限公司 | 江苏飞马药业有限公司 | 国药准字H20265320 | 2026/07/21 | 1mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 浙江普利药业有限公司 | 浙江普利药业有限公司 | 国药准字H20265318 | 2026/07/21 | 1mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 浙江诺得药业有限公司 | 浙江诺得药业有限公司 | 国药准字H20265276 | 2026/07/21 | 1mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 浙江诺得药业有限公司 | 浙江诺得药业有限公司 | 国药准字H20265275 | 2026/07/21 | 0.5mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 浙江普利药业有限公司 | 浙江普利药业有限公司 | 国药准字H20265317 | 2026/07/21 | 2mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 浙江普利药业有限公司 | 浙江普利药业有限公司 | 国药准字H20265319 | 2026/07/21 | 0.5mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 江苏飞马药业有限公司 | 江苏飞马药业有限公司 | 国药准字H20265322 | 2026/07/21 | 4mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 石药集团欧意药业有限公司 | 石药集团欧意药业有限公司 | 国药准字H20265017 | 2026/06/30 | 1mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 石药集团欧意药业有限公司 | 石药集团欧意药业有限公司 | 国药准字H20265016 | 2026/06/30 | 2mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 石药集团欧意药业有限公司 | 石药集团欧意药业有限公司 | 国药准字H20265018 | 2026/06/30 | 0.5mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 合肥英太制药有限公司 | 合肥英太制药有限公司 | 国药准字H20264750 | 2026/06/10 | 1mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 合肥英太制药有限公司 | 合肥英太制药有限公司 | 国药准字H20264749 | 2026/06/10 | 2mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 浙江华海药业股份有限公司 | 浙江华海药业股份有限公司 | 国药准字H20264516 | 2026/05/27 | 2mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 浙江华海药业股份有限公司 | 浙江华海药业股份有限公司 | 国药准字H20264517 | 2026/05/27 | 1mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 浙江华海药业股份有限公司 | 浙江华海药业股份有限公司 | 国药准字H20264518 | 2026/05/27 | 0.5mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 重庆药友制药有限责任公司 | 重庆药友制药有限责任公司 | 国药准字H20264251 | 2026/05/07 | 4mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 重庆药友制药有限责任公司 | 重庆药友制药有限责任公司 | 国药准字H20264250 | 2026/05/07 | 1mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 重庆药友制药有限责任公司 | 重庆药友制药有限责任公司 | 国药准字H20264252 | 2026/05/07 | 2mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 江西泰吉立生物医药科技有限公司 | 浙江赛默制药有限公司 | 国药准字H20264242 | 2026/05/07 | 2mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 江西泰吉立生物医药科技有限公司 | 浙江赛默制药有限公司 | 国药准字H20264241 | 2026/05/07 | 1mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 浙江诺得药业有限公司 | 浙江诺得药业有限公司 | 国药准字H20263938 | 2026/04/14 | 2mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 湖南科伦制药有限公司 | 湖南科伦制药有限公司 | 国药准字H20263977 | 2026/04/14 | 2mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 湖南科伦制药有限公司 | 湖南科伦制药有限公司 | 国药准字H20263978 | 2026/04/14 | 1mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 天津药物研究院药业有限责任公司 | 天津药物研究院药业有限责任公司 | 国药准字H20263879 | 2026/04/07 | 1mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 天津药物研究院药业有限责任公司 | 天津药物研究院药业有限责任公司 | 国药准字H20263878 | 2026/04/07 | 2mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 远大医药（西安）有限公司 | 西安远大德天药业股份有限公司 | 国药准字H20263598 | 2026/03/17 | 2mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 远大医药（西安）有限公司 | 西安远大德天药业股份有限公司 | 国药准字H20263597 | 2026/03/17 | 1mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 哈尔滨珍宝制药有限公司 | 哈尔滨珍宝制药有限公司 | 国药准字H20263514 | 2026/03/03 | 1mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 哈尔滨珍宝制药有限公司 | 哈尔滨珍宝制药有限公司 | 国药准字H20263513 | 2026/03/03 | 2mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 成都康弘药业集团股份有限公司 | 成都康弘药业集团股份有限公司 | 国药准字H20256389 | 2025/12/22 | 1mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 成都康弘药业集团股份有限公司 | 成都康弘药业集团股份有限公司 | 国药准字H20256388 | 2025/12/22 | 2mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 辰欣药业股份有限公司 | 辰欣药业股份有限公司 | 国药准字H20256271 | 2025/12/16 | 1mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 辰欣药业股份有限公司 | 辰欣药业股份有限公司 | 国药准字H20256272 | 2025/12/16 | 2mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 北京海步医药科技有限公司 | 石家庄龙泽制药股份有限公司 | 国药准字H20256330 | 2025/12/16 | 2mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 齐鲁制药有限公司 | 齐鲁制药有限公司 | 国药准字H20256227 | 2025/12/09 | 1mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 齐鲁制药有限公司 | 齐鲁制药有限公司 | 国药准字H20256228 | 2025/12/09 | 0.5mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 成都苑东生物制药股份有限公司 | 成都苑东生物制药股份有限公司 | 国药准字H20256115 | 2025/12/03 | 2mg | Not stated by source | CDE |
| 成都苑东生物制药股份有限公司 | 成都苑东生物制药股份有限公司 | 国药准字H20256114 | 2025/12/03 | 1mg | Not stated by source | CDE |
| 成都苑东生物制药股份有限公司 | 成都苑东生物制药股份有限公司 | 国药准字H20256116 | 2025/12/03 | 4mg | Not stated by source | CDE |
| 宜昌人福药业有限责任公司 | 宜昌人福药业有限责任公司 | 国药准字H20265400 | 2026/07/28 | 2mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 宜昌人福药业有限责任公司 | 宜昌人福药业有限责任公司 | 国药准字H20265401 | 2026/07/28 | 1mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 海南广升誉制药有限公司 | 华益泰康药业股份有限公司 | 国药准字H20265395 | 2026/07/28 | 1mg | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
NHSA drug codes
Loaded records: 56 distinct approval numbers and 24 companies.
| Company / applicant | Approval number | Strength / specification | NHSA class | NHSA drug code | View source |
|---|---|---|---|---|---|
| 天津药物研究院药业有限责任公司 | 国药准字H20263878 | 2mg | Not stated by source | XN05AXB266A001010100951 | NHSA |
| 重庆药友制药有限责任公司 | 国药准字H20264252 | 2mg | Not stated by source | XN05AXB266A001010101066 | NHSA |
| 江苏康缘药业股份有限公司 | 国药准字H20265534 | 0.5mg | Not stated by source | XN05AXB266A001010101463 | NHSA |
| 江苏飞马药业有限公司 | 国药准字H20265320 | 1mg | Not stated by source | XN05AXB266A001010101614 | NHSA |
| 成都康弘药业集团股份有限公司 | 国药准字H20256388 | 2mg | Not stated by source | XN05AXB266A001010102016 | NHSA |
| 成都苑东生物制药股份有限公司 | 国药准字H20256114 | 1mg | Not stated by source | XN05AXB266A001010102181 | NHSA |
| 远大医药(西安)有限公司 | 国药准字H20263597 | 1mg | Not stated by source | XN05AXB266A001010102469 | NHSA |
| 石药集团欧意药业有限公司 | 国药准字H20265016 | 2mg | Not stated by source | XN05AXB266A001010102770 | NHSA |
| 哈尔滨三联药业股份有限公司 | 国药准字H20265893 | 2mg | Not stated by source | XN05AXB266A001010103662 | NHSA |
| 齐鲁制药有限公司 | 国药准字H20256227 | 1mg | Not stated by source | XN05AXB266A001010104021 | NHSA |
| 山东京卫制药有限公司 | 国药准字H20265368 | 0.5mg | Not stated by source | XN05AXB266A001010104111 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20256272 | 2mg | Not stated by source | XN05AXB266A001010104127 | NHSA |
| 浙江华海药业股份有限公司 | 国药准字H20264518 | 0.5mg | Not stated by source | XN05AXB266A001010104647 | NHSA |
| 湖南科伦制药有限公司 | 国药准字H20263978 | 1mg | Not stated by source | XN05AXB266A001010104948 | NHSA |
| 重庆圣华曦药业股份有限公司 | 国药准字H20265684 | 1mg | Not stated by source | XN05AXB266A001010109568 | NHSA |
| Otsuka Pharmaceutical Co., Ltd. | 国药准字HJ20240050 | 1mg | Not stated by source | XN05AXB266A001010179080 | NHSA |
| 合肥英太制药有限公司 | 国药准字H20264749 | 2mg | Not stated by source | XN05AXB266A001010180698 | NHSA |
| 海南广升誉制药有限公司 | 国药准字H20265395 | 1mg | Not stated by source | XN05AXB266A001010181251 | NHSA |
| 杭州和康药业有限公司 | 国药准字H20266181 | 2mg | Not stated by source | XN05AXB266A001010181760 | NHSA |
| 浙江普利药业有限公司 | 国药准字H20265318 | 1mg | Not stated by source | XN05AXB266A001010182922 | NHSA |
| 山东鲁抗医药股份有限公司 | 国药准字H20265543 | 0.25mg | Not stated by source | XN05AXB266A001010183198 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20263938 | 2mg | Not stated by source | XN05AXB266A001010183521 | NHSA |
| 北京海步医药科技有限公司 | 国药准字H20256330 | 2mg | Not stated by source | XN05AXB266A001010183603 | NHSA |
| 江西泰吉立生物医药科技有限公司 | 国药准字H20264241 | 1mg | Not stated by source | XN05AXB266A001010184945 | NHSA |
| 天津药物研究院药业有限责任公司 | 国药准字H20263878 | 2mg | Not stated by source | XN05AXB266A001010200951 | NHSA |
| 江苏康缘药业股份有限公司 | 国药准字H20265534 | 0.5mg | Not stated by source | XN05AXB266A001010201463 | NHSA |
| 成都康弘药业集团股份有限公司 | 国药准字H20256388 | 2mg | Not stated by source | XN05AXB266A001010202016 | NHSA |
| 哈尔滨三联药业股份有限公司 | 国药准字H20265893 | 2mg | Not stated by source | XN05AXB266A001010203662 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20256272 | 2mg | Not stated by source | XN05AXB266A001010204127 | NHSA |
| 湖南科伦制药有限公司 | 国药准字H20263978 | 1mg | Not stated by source | XN05AXB266A001010204948 | NHSA |
| 重庆圣华曦药业股份有限公司 | 国药准字H20265684 | 1mg | Not stated by source | XN05AXB266A001010209568 | NHSA |
| 合肥英太制药有限公司 | 国药准字H20264749 | 2mg | Not stated by source | XN05AXB266A001010280698 | NHSA |
| 浙江普利药业有限公司 | 国药准字H20265318 | 1mg | Not stated by source | XN05AXB266A001010282922 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20263938 | 2mg | Not stated by source | XN05AXB266A001010283521 | NHSA |
| 北京海步医药科技有限公司 | 国药准字H20256330 | 2mg | Not stated by source | XN05AXB266A001010283603 | NHSA |
| 江西泰吉立生物医药科技有限公司 | 国药准字H20264241 | 1mg | Not stated by source | XN05AXB266A001010284945 | NHSA |
| 江苏康缘药业股份有限公司 | 国药准字H20265534 | 0.5mg | Not stated by source | XN05AXB266A001010301463 | NHSA |
| 成都康弘药业集团股份有限公司 | 国药准字H20256388 | 2mg | Not stated by source | XN05AXB266A001010302016 | NHSA |
| 哈尔滨三联药业股份有限公司 | 国药准字H20265893 | 2mg | Not stated by source | XN05AXB266A001010303662 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20256272 | 2mg | Not stated by source | XN05AXB266A001010304127 | NHSA |
| 重庆圣华曦药业股份有限公司 | 国药准字H20265684 | 1mg | Not stated by source | XN05AXB266A001010309568 | NHSA |
| 合肥英太制药有限公司 | 国药准字H20264749 | 2mg | Not stated by source | XN05AXB266A001010380698 | NHSA |
| 浙江普利药业有限公司 | 国药准字H20265318 | 1mg | Not stated by source | XN05AXB266A001010382922 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20263938 | 2mg | Not stated by source | XN05AXB266A001010383521 | NHSA |
| 北京海步医药科技有限公司 | 国药准字H20256330 | 2mg | Not stated by source | XN05AXB266A001010383603 | NHSA |
| 江西泰吉立生物医药科技有限公司 | 国药准字H20264241 | 1mg | Not stated by source | XN05AXB266A001010384945 | NHSA |
| 成都康弘药业集团股份有限公司 | 国药准字H20256388 | 2mg | Not stated by source | XN05AXB266A001010402016 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20256272 | 2mg | Not stated by source | XN05AXB266A001010404127 | NHSA |
| 重庆圣华曦药业股份有限公司 | 国药准字H20265684 | 1mg | Not stated by source | XN05AXB266A001010409568 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20263938 | 2mg | Not stated by source | XN05AXB266A001010483521 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20256272 | 2mg | Not stated by source | XN05AXB266A001010504127 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20263938 | 2mg | Not stated by source | XN05AXB266A001010583521 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20256272 | 2mg | Not stated by source | XN05AXB266A001010604127 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20263938 | 2mg | Not stated by source | XN05AXB266A001010683521 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20256272 | 2mg | Not stated by source | XN05AXB266A001010704127 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20263938 | 2mg | Not stated by source | XN05AXB266A001010783521 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20256272 | 2mg | Not stated by source | XN05AXB266A001010804127 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20263938 | 2mg | Not stated by source | XN05AXB266A001010883521 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20256272 | 2mg | Not stated by source | XN05AXB266A001010904127 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20263938 | 2mg | Not stated by source | XN05AXB266A001010983521 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20256272 | 2mg | Not stated by source | XN05AXB266A001011004127 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20263938 | 2mg | Not stated by source | XN05AXB266A001011083521 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20256272 | 2mg | Not stated by source | XN05AXB266A001011104127 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20263938 | 2mg | Not stated by source | XN05AXB266A001011183521 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20256272 | 2mg | Not stated by source | XN05AXB266A001011204127 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20263938 | 2mg | Not stated by source | XN05AXB266A001011283521 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20256272 | 2mg | Not stated by source | XN05AXB266A001011304127 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20263938 | 2mg | Not stated by source | XN05AXB266A001011383521 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20256272 | 2mg | Not stated by source | XN05AXB266A001011404127 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20263938 | 2mg | Not stated by source | XN05AXB266A001011483521 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20256272 | 2mg | Not stated by source | XN05AXB266A001011504127 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20263938 | 2mg | Not stated by source | XN05AXB266A001011583521 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20256272 | 2mg | Not stated by source | XN05AXB266A001011604127 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20263938 | 2mg | Not stated by source | XN05AXB266A001011683521 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20256272 | 2mg | Not stated by source | XN05AXB266A001011704127 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20263938 | 2mg | Not stated by source | XN05AXB266A001011783521 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20256272 | 2mg | Not stated by source | XN05AXB266A001011804127 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20263938 | 2mg | Not stated by source | XN05AXB266A001011883521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20263938 | 2mg | Not stated by source | XN05AXB266A001011983521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20263938 | 2mg | Not stated by source | XN05AXB266A001012083521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20263938 | 2mg | Not stated by source | XN05AXB266A001012183521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20263938 | 2mg | Not stated by source | XN05AXB266A001012283521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20263938 | 2mg | Not stated by source | XN05AXB266A001012383521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20263938 | 2mg | Not stated by source | XN05AXB266A001012483521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20263938 | 2mg | Not stated by source | XN05AXB266A001012583521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20263938 | 2mg | Not stated by source | XN05AXB266A001012683521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20263938 | 2mg | Not stated by source | XN05AXB266A001012783521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20263938 | 2mg | Not stated by source | XN05AXB266A001012883521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20263938 | 2mg | Not stated by source | XN05AXB266A001012983521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20263938 | 2mg | Not stated by source | XN05AXB266A001013083521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20263938 | 2mg | Not stated by source | XN05AXB266A001013183521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20263938 | 2mg | Not stated by source | XN05AXB266A001013283521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20263938 | 2mg | Not stated by source | XN05AXB266A001013383521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20263938 | 2mg | Not stated by source | XN05AXB266A001013483521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20263938 | 2mg | Not stated by source | XN05AXB266A001013583521 | NHSA |
| 天津药物研究院药业有限责任公司 | 国药准字H20263879 | 1mg | Not stated by source | XN05AXB266A001020100951 | NHSA |
| 重庆药友制药有限责任公司 | 国药准字H20264251 | 4mg | Not stated by source | XN05AXB266A001020101066 | NHSA |
| 江苏康缘药业股份有限公司 | 国药准字H20265535 | 1mg | Not stated by source | XN05AXB266A001020101463 | NHSA |
| 江苏飞马药业有限公司 | 国药准字H20265322 | 4mg | Not stated by source | XN05AXB266A001020101614 | NHSA |
| 成都康弘药业集团股份有限公司 | 国药准字H20256389 | 1mg | Not stated by source | XN05AXB266A001020102016 | NHSA |
| 成都苑东生物制药股份有限公司 | 国药准字H20256115 | 2mg | Not stated by source | XN05AXB266A001020102181 | NHSA |
| 远大医药(西安)有限公司 | 国药准字H20263598 | 2mg | Not stated by source | XN05AXB266A001020102469 | NHSA |
| 石药集团欧意药业有限公司 | 国药准字H20265017 | 1mg | Not stated by source | XN05AXB266A001020102770 | NHSA |
| 哈尔滨三联药业股份有限公司 | 国药准字H20265894 | 1mg | Not stated by source | XN05AXB266A001020103662 | NHSA |
| 齐鲁制药有限公司 | 国药准字H20256228 | 0.5mg | Not stated by source | XN05AXB266A001020104021 | NHSA |
| 山东京卫制药有限公司 | 国药准字H20265367 | 1mg | Not stated by source | XN05AXB266A001020104111 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20256271 | 1mg | Not stated by source | XN05AXB266A001020104127 | NHSA |
| 浙江华海药业股份有限公司 | 国药准字H20264517 | 1mg | Not stated by source | XN05AXB266A001020104647 | NHSA |
| 湖南科伦制药有限公司 | 国药准字H20263977 | 2mg | Not stated by source | XN05AXB266A001020104948 | NHSA |
| 重庆圣华曦药业股份有限公司 | 国药准字H20265683 | 2mg | Not stated by source | XN05AXB266A001020109568 | NHSA |
| Otsuka Pharmaceutical Co., Ltd. | 国药准字HJ20240051 | 2mg | Not stated by source | XN05AXB266A001020179080 | NHSA |
| 合肥英太制药有限公司 | 国药准字H20264750 | 1mg | Not stated by source | XN05AXB266A001020180698 | NHSA |
| 海南广升誉制药有限公司 | 国药准字H20265396 | 2mg | Not stated by source | XN05AXB266A001020181251 | NHSA |
| 杭州和康药业有限公司 | 国药准字H20266182 | 1mg | Not stated by source | XN05AXB266A001020181760 | NHSA |
| 山东鲁抗医药股份有限公司 | 国药准字H20265542 | 1mg | Not stated by source | XN05AXB266A001020183198 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20265275 | 0.5mg | Not stated by source | XN05AXB266A001020183521 | NHSA |
| 江西泰吉立生物医药科技有限公司 | 国药准字H20264242 | 2mg | Not stated by source | XN05AXB266A001020184945 | NHSA |
| 天津药物研究院药业有限责任公司 | 国药准字H20263879 | 1mg | Not stated by source | XN05AXB266A001020200951 | NHSA |
| 江苏康缘药业股份有限公司 | 国药准字H20265535 | 1mg | Not stated by source | XN05AXB266A001020201463 | NHSA |
| 成都康弘药业集团股份有限公司 | 国药准字H20256389 | 1mg | Not stated by source | XN05AXB266A001020202016 | NHSA |
| 哈尔滨三联药业股份有限公司 | 国药准字H20265894 | 1mg | Not stated by source | XN05AXB266A001020203662 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20256271 | 1mg | Not stated by source | XN05AXB266A001020204127 | NHSA |
| 湖南科伦制药有限公司 | 国药准字H20263977 | 2mg | Not stated by source | XN05AXB266A001020204948 | NHSA |
| 重庆圣华曦药业股份有限公司 | 国药准字H20265683 | 2mg | Not stated by source | XN05AXB266A001020209568 | NHSA |
| 合肥英太制药有限公司 | 国药准字H20264750 | 1mg | Not stated by source | XN05AXB266A001020280698 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20265275 | 0.5mg | Not stated by source | XN05AXB266A001020283521 | NHSA |
| 江西泰吉立生物医药科技有限公司 | 国药准字H20264242 | 2mg | Not stated by source | XN05AXB266A001020284945 | NHSA |
| 江苏康缘药业股份有限公司 | 国药准字H20265535 | 1mg | Not stated by source | XN05AXB266A001020301463 | NHSA |
| 成都康弘药业集团股份有限公司 | 国药准字H20256389 | 1mg | Not stated by source | XN05AXB266A001020302016 | NHSA |
| 哈尔滨三联药业股份有限公司 | 国药准字H20265894 | 1mg | Not stated by source | XN05AXB266A001020303662 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20256271 | 1mg | Not stated by source | XN05AXB266A001020304127 | NHSA |
| 重庆圣华曦药业股份有限公司 | 国药准字H20265683 | 2mg | Not stated by source | XN05AXB266A001020309568 | NHSA |
| 合肥英太制药有限公司 | 国药准字H20264750 | 1mg | Not stated by source | XN05AXB266A001020380698 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20265275 | 0.5mg | Not stated by source | XN05AXB266A001020383521 | NHSA |
| 江西泰吉立生物医药科技有限公司 | 国药准字H20264242 | 2mg | Not stated by source | XN05AXB266A001020384945 | NHSA |
| 成都康弘药业集团股份有限公司 | 国药准字H20256389 | 1mg | Not stated by source | XN05AXB266A001020402016 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20256271 | 1mg | Not stated by source | XN05AXB266A001020404127 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20265275 | 0.5mg | Not stated by source | XN05AXB266A001020483521 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20256271 | 1mg | Not stated by source | XN05AXB266A001020504127 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20265275 | 0.5mg | Not stated by source | XN05AXB266A001020583521 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20256271 | 1mg | Not stated by source | XN05AXB266A001020604127 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20265275 | 0.5mg | Not stated by source | XN05AXB266A001020683521 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20256271 | 1mg | Not stated by source | XN05AXB266A001020704127 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20265275 | 0.5mg | Not stated by source | XN05AXB266A001020783521 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20256271 | 1mg | Not stated by source | XN05AXB266A001020804127 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20265275 | 0.5mg | Not stated by source | XN05AXB266A001020883521 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20256271 | 1mg | Not stated by source | XN05AXB266A001020904127 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20265275 | 0.5mg | Not stated by source | XN05AXB266A001020983521 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20256271 | 1mg | Not stated by source | XN05AXB266A001021004127 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20265275 | 0.5mg | Not stated by source | XN05AXB266A001021083521 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20256271 | 1mg | Not stated by source | XN05AXB266A001021104127 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20265275 | 0.5mg | Not stated by source | XN05AXB266A001021183521 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20256271 | 1mg | Not stated by source | XN05AXB266A001021204127 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20265275 | 0.5mg | Not stated by source | XN05AXB266A001021283521 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20256271 | 1mg | Not stated by source | XN05AXB266A001021304127 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20265275 | 0.5mg | Not stated by source | XN05AXB266A001021383521 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20256271 | 1mg | Not stated by source | XN05AXB266A001021404127 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20265275 | 0.5mg | Not stated by source | XN05AXB266A001021483521 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20256271 | 1mg | Not stated by source | XN05AXB266A001021504127 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20265275 | 0.5mg | Not stated by source | XN05AXB266A001021583521 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20256271 | 1mg | Not stated by source | XN05AXB266A001021604127 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20265275 | 0.5mg | Not stated by source | XN05AXB266A001021683521 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20256271 | 1mg | Not stated by source | XN05AXB266A001021704127 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20265275 | 0.5mg | Not stated by source | XN05AXB266A001021783521 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20256271 | 1mg | Not stated by source | XN05AXB266A001021804127 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20265275 | 0.5mg | Not stated by source | XN05AXB266A001021883521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20265275 | 0.5mg | Not stated by source | XN05AXB266A001021983521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20265275 | 0.5mg | Not stated by source | XN05AXB266A001022083521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20265275 | 0.5mg | Not stated by source | XN05AXB266A001022183521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20265275 | 0.5mg | Not stated by source | XN05AXB266A001022283521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20265275 | 0.5mg | Not stated by source | XN05AXB266A001022383521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20265275 | 0.5mg | Not stated by source | XN05AXB266A001022483521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20265275 | 0.5mg | Not stated by source | XN05AXB266A001022583521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20265275 | 0.5mg | Not stated by source | XN05AXB266A001022683521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20265275 | 0.5mg | Not stated by source | XN05AXB266A001022783521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20265275 | 0.5mg | Not stated by source | XN05AXB266A001022883521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20265275 | 0.5mg | Not stated by source | XN05AXB266A001022983521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20265275 | 0.5mg | Not stated by source | XN05AXB266A001023083521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20265275 | 0.5mg | Not stated by source | XN05AXB266A001023183521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20265275 | 0.5mg | Not stated by source | XN05AXB266A001023283521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20265275 | 0.5mg | Not stated by source | XN05AXB266A001023383521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20265275 | 0.5mg | Not stated by source | XN05AXB266A001023483521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20265275 | 0.5mg | Not stated by source | XN05AXB266A001023583521 | NHSA |
| 重庆药友制药有限责任公司 | 国药准字H20264250 | 1mg | Not stated by source | XN05AXB266A001030101066 | NHSA |
| 江苏康缘药业股份有限公司 | 国药准字H20265536 | 2mg | Not stated by source | XN05AXB266A001030101463 | NHSA |
| 江苏飞马药业有限公司 | 国药准字H20265321 | 2mg | Not stated by source | XN05AXB266A001030101614 | NHSA |
| 成都苑东生物制药股份有限公司 | 国药准字H20256116 | 4mg | Not stated by source | XN05AXB266A001030102181 | NHSA |
| 石药集团欧意药业有限公司 | 国药准字H20265018 | 0.5mg | Not stated by source | XN05AXB266A001030102770 | NHSA |
| 山东京卫制药有限公司 | 国药准字H20265366 | 2mg | Not stated by source | XN05AXB266A001030104111 | NHSA |
| 浙江华海药业股份有限公司 | 国药准字H20264516 | 2mg | Not stated by source | XN05AXB266A001030104647 | NHSA |
| 杭州和康药业有限公司 | 国药准字H20266183 | 0.5mg | Not stated by source | XN05AXB266A001030181760 | NHSA |
| 山东鲁抗医药股份有限公司 | 国药准字H20265541 | 2mg | Not stated by source | XN05AXB266A001030183198 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20265276 | 1mg | Not stated by source | XN05AXB266A001030183521 | NHSA |
| 江苏康缘药业股份有限公司 | 国药准字H20265536 | 2mg | Not stated by source | XN05AXB266A001030201463 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20265276 | 1mg | Not stated by source | XN05AXB266A001030283521 | NHSA |
| 江苏康缘药业股份有限公司 | 国药准字H20265536 | 2mg | Not stated by source | XN05AXB266A001030301463 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20265276 | 1mg | Not stated by source | XN05AXB266A001030383521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20265276 | 1mg | Not stated by source | XN05AXB266A001030483521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20265276 | 1mg | Not stated by source | XN05AXB266A001030583521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20265276 | 1mg | Not stated by source | XN05AXB266A001030683521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20265276 | 1mg | Not stated by source | XN05AXB266A001030783521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20265276 | 1mg | Not stated by source | XN05AXB266A001030883521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20265276 | 1mg | Not stated by source | XN05AXB266A001030983521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20265276 | 1mg | Not stated by source | XN05AXB266A001031083521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20265276 | 1mg | Not stated by source | XN05AXB266A001031183521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20265276 | 1mg | Not stated by source | XN05AXB266A001031283521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20265276 | 1mg | Not stated by source | XN05AXB266A001031383521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20265276 | 1mg | Not stated by source | XN05AXB266A001031483521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20265276 | 1mg | Not stated by source | XN05AXB266A001031583521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20265276 | 1mg | Not stated by source | XN05AXB266A001031683521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20265276 | 1mg | Not stated by source | XN05AXB266A001031783521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20265276 | 1mg | Not stated by source | XN05AXB266A001031883521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20265276 | 1mg | Not stated by source | XN05AXB266A001031983521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20265276 | 1mg | Not stated by source | XN05AXB266A001032083521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20265276 | 1mg | Not stated by source | XN05AXB266A001032183521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20265276 | 1mg | Not stated by source | XN05AXB266A001032283521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20265276 | 1mg | Not stated by source | XN05AXB266A001032383521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20265276 | 1mg | Not stated by source | XN05AXB266A001032483521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20265276 | 1mg | Not stated by source | XN05AXB266A001032583521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20265276 | 1mg | Not stated by source | XN05AXB266A001032683521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20265276 | 1mg | Not stated by source | XN05AXB266A001032783521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20265276 | 1mg | Not stated by source | XN05AXB266A001032883521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20265276 | 1mg | Not stated by source | XN05AXB266A001032983521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20265276 | 1mg | Not stated by source | XN05AXB266A001033083521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20265276 | 1mg | Not stated by source | XN05AXB266A001033183521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20265276 | 1mg | Not stated by source | XN05AXB266A001033283521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20265276 | 1mg | Not stated by source | XN05AXB266A001033383521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20265276 | 1mg | Not stated by source | XN05AXB266A001033483521 | NHSA |
| 浙江诺得药业有限公司 | 国药准字H20265276 | 1mg | Not stated by source | XN05AXB266A001033583521 | NHSA |
Approval numbers and companies are deduplicated separately; packaging records remain individually listed. An empty insurance class means it is unstated. NHSA codes supply no approval date and do not establish the outcome of an acceptance number.
Current under-review applications
Loaded records: 31 filings and 12 distinct first applicants.
Generic 28 · Supplement 3
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| 海南通用三洋药业有限公司 | CYHS2504432 | Generic | 2025/12/26 | Not stated by source | CDE |
| 海南通用三洋药业有限公司 | CYHS2504431 | Generic | 2025/12/26 | Not stated by source | CDE |
| 海南通用三洋药业有限公司 | CYHS2504430 | Generic | 2025/12/26 | Not stated by source | CDE |
| 北京海步医药科技有限公司;石家庄龙泽制药股份有限公司 | CYHB2601890 | Supplement | 2026/10/14 | Not stated by source | CDE |
| 北京海步医药科技有限公司;石家庄龙泽制药股份有限公司 | CYHB2601889 | Supplement | 2026/10/14 | Not stated by source | CDE |
| 北京海步医药科技有限公司;石家庄龙泽制药股份有限公司 | CYHB2601888 | Supplement | 2026/10/14 | Not stated by source | CDE |
| 山东信谊制药有限公司 | CYHS2601991 | Generic | 2026/08/13 | Not stated by source | CDE |
| 山东信谊制药有限公司 | CYHS2601990 | Generic | 2026/08/13 | Not stated by source | CDE |
| 山东信谊制药有限公司 | CYHS2601989 | Generic | 2026/08/13 | Not stated by source | CDE |
| 浙江华义制药有限公司 | CYHS2601356 | Generic | 2026/06/10 | Not stated by source | CDE |
| 浙江华义制药有限公司 | CYHS2601355 | Generic | 2026/06/10 | Not stated by source | CDE |
| 湖南一格制药有限公司 | CYHS2601160 | Generic | 2026/05/14 | Not stated by source | CDE |
| 湖南一格制药有限公司 | CYHS2601159 | Generic | 2026/05/14 | Not stated by source | CDE |
| 湖南一格制药有限公司 | CYHS2601158 | Generic | 2026/05/14 | Not stated by source | CDE |
| 宜昌东阳光长江药业股份有限公司 | CYHS2600097 | Generic | 2026/01/08 | Not stated by source | CDE |
| 宜昌东阳光长江药业股份有限公司 | CYHS2600096 | Generic | 2026/01/08 | Not stated by source | CDE |
| 宜昌东阳光长江药业股份有限公司 | CYHS2600095 | Generic | 2026/01/08 | Not stated by source | CDE |
| 西南药业股份有限公司 | CYHS2600021 | Generic | 2026/01/05 | Not stated by source | CDE |
| 华润双鹤湘中药业（湖南）有限公司 | CYHS2504397 | Generic | 2025/12/25 | Not stated by source | CDE |
| 华润双鹤湘中药业（湖南）有限公司 | CYHS2504396 | Generic | 2025/12/25 | Not stated by source | CDE |
| 成都通德药业有限公司 | CYHS2503945 | Generic | 2025/11/13 | Not stated by source | CDE |
| 成都通德药业有限公司 | CYHS2503944 | Generic | 2025/11/13 | Not stated by source | CDE |
| 成都通德药业有限公司 | CYHS2503943 | Generic | 2025/11/13 | Not stated by source | CDE |
| 杭州和泽坤元药业有限公司;浙江皓格药业有限公司 | CYHS2503472 | Generic | 2025/09/19 | Not stated by source | CDE |
| 杭州和泽坤元药业有限公司;浙江皓格药业有限公司 | CYHS2503471 | Generic | 2025/09/19 | Not stated by source | CDE |
| 马应龙药业集团股份有限公司 | CYHS2503295 | Generic | 2025/09/05 | Not stated by source | CDE |
| 马应龙药业集团股份有限公司 | CYHS2503294 | Generic | 2025/09/05 | Not stated by source | CDE |
| 马应龙药业集团股份有限公司 | CYHS2503293 | Generic | 2025/09/05 | Not stated by source | CDE |
| 宁波大红鹰药业股份有限公司 | CYHS2501710 | Generic | 2025/05/12 | Not stated by source | CDE |
| 宁波大红鹰药业股份有限公司 | CYHS2501709 | Generic | 2025/05/12 | Not stated by source | CDE |
| 宁波大红鹰药业股份有限公司 | CYHS2501708 | Generic | 2025/05/12 | Not stated by source | CDE |
New generic filings in 2026
Loaded records: 12 filings and 5 distinct first applicants.
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| 山东信谊制药有限公司 | CYHS2601991 | Generic | 2026/08/13 | Not stated by source | CDE |
| 山东信谊制药有限公司 | CYHS2601990 | Generic | 2026/08/13 | Not stated by source | CDE |
| 山东信谊制药有限公司 | CYHS2601989 | Generic | 2026/08/13 | Not stated by source | CDE |
| 浙江华义制药有限公司 | CYHS2601356 | Generic | 2026/06/10 | Not stated by source | CDE |
| 浙江华义制药有限公司 | CYHS2601355 | Generic | 2026/06/10 | Not stated by source | CDE |
| 湖南一格制药有限公司 | CYHS2601160 | Generic | 2026/05/14 | Not stated by source | CDE |
| 湖南一格制药有限公司 | CYHS2601159 | Generic | 2026/05/14 | Not stated by source | CDE |
| 湖南一格制药有限公司 | CYHS2601158 | Generic | 2026/05/14 | Not stated by source | CDE |
| 宜昌东阳光长江药业股份有限公司 | CYHS2600097 | Generic | 2026/01/08 | Not stated by source | CDE |
| 宜昌东阳光长江药业股份有限公司 | CYHS2600096 | Generic | 2026/01/08 | Not stated by source | CDE |
| 宜昌东阳光长江药业股份有限公司 | CYHS2600095 | Generic | 2026/01/08 | Not stated by source | CDE |
| 西南药业股份有限公司 | CYHS2600021 | Generic | 2026/01/05 | Not stated by source | CDE |
API registrations
Non-component matches: 30 companies with A status and 5 I-status records. Component matches are listed separately and excluded from these counts.
| Name | Company / applicant | Registration number | Status | Name match | Source update date | View source |
|---|---|---|---|---|---|---|
| 布瑞哌唑 | 河北广祥制药有限公司 | Y20260000216 | I | Exact ingredient | 2026/04/07 | CDE |
| 布瑞哌唑 | 湖南一格制药有限公司 | Y20260000066 | I | Exact ingredient | 2026/02/14 | CDE |
| 布瑞哌唑 | 山东信谊制药有限公司 | Y20250001338 | I | Exact ingredient | 2025/12/23 | CDE |
| 布瑞哌唑 | 甘肃海普诺睿创制药有限公司 | Y20250001255 | I | Exact ingredient | 2025/12/10 | CDE |
| 布瑞哌唑 | 乳源东阳光药业有限公司 | Y20250000540 | I | Exact ingredient | 2025/06/06 | CDE |
| 布瑞哌唑 | 云鹏医药集团有限公司 | Y20250000268 | A | Exact ingredient | 2026/08/13 | CDE |
| 布瑞哌唑 | 江苏恩华药业股份有限公司 | Y20250000258 | A | Exact ingredient | 2026/08/06 | CDE |
| 布瑞哌唑 | 广东先强药业有限公司 | Y20250000228 | A | Exact ingredient | 2026/07/28 | CDE |
| 布瑞哌唑 | 华润双鹤湘中药业（湖南）有限公司 | Y20250000127 | A | Exact ingredient | 2026/09/21 | CDE |
| 布瑞哌唑 | 江苏正大丰海制药有限公司 | Y20250000085 | A | Exact ingredient | 2026/06/01 | CDE |
| 布瑞哌唑 | 石药集团欧意药业有限公司 | Y20240001524 | A | Exact ingredient | 2026/07/04 | CDE |
| 布瑞哌唑 | 甘肃皓天医药科技有限责任公司 | Y20240001562 | A | Exact ingredient | 2026/08/13 | CDE |
| 布瑞哌唑 | 重庆圣华曦药业股份有限公司 | Y20240001555 | A | Exact ingredient | 2026/08/24 | CDE |
| 布瑞哌唑 | 山东鲁抗医药股份有限公司 | Y20240001517 | A | Exact ingredient | 2026/10/09 | CDE |
| 布瑞哌唑 | 山东新时代药业有限公司 | Y20240001445 | A | Exact ingredient | 2026/07/21 | CDE |
| 布瑞哌唑 | 北京福元医药股份有限公司 | Y20240001452 | A | Exact ingredient | 2026/04/22 | CDE |
| 布瑞哌唑 | 浙江京圣药业有限公司 | Y20240001143 | A | Exact ingredient | 2026/07/13 | CDE |
| 布瑞哌唑 | 天津泰普制药有限公司 | Y20240000883 | A | Exact ingredient | 2025/12/29 | CDE |
| 布瑞哌唑 | 辽宁北峰药业有限公司 | Y20240000819 | A | Exact ingredient | 2026/03/06 | CDE |
| 布瑞哌唑 | 浙江赛默制药有限公司 | Y20240000877 | A | Exact ingredient | 2026/05/20 | CDE |
| 布瑞哌唑 | 浙江国邦药业有限公司 | Y20240000722 | A | Exact ingredient | 2026/09/13 | CDE |
| 布瑞哌唑 | 浙江华海药业股份有限公司 | Y20240000766 | A | Exact ingredient | 2026/03/19 | CDE |
| 布瑞哌唑 | 四川弘远药业有限公司 | Y20240000696 | A | Exact ingredient | 2026/08/11 | CDE |
| 布瑞哌唑 | 扬子江药业集团江苏海慈生物药业有限公司 | Y20240000533 | A | Exact ingredient | 2025/11/28 | CDE |
| 布瑞哌唑 | 山东辰龙药业有限公司 | Y20240000693 | A | Exact ingredient | 2025/11/14 | CDE |
| 布瑞哌唑 | 山东安弘制药有限公司 | Y20240000591 | A | Exact ingredient | 2025/12/14 | CDE |
| 布瑞哌唑 | 四川青木制药有限公司 | Y20240000436 | A | Exact ingredient | 2025/08/22 | CDE |
| 布瑞哌唑 | 兰西哈三联制药有限公司 | Y20230001153 | A | Exact ingredient | 2026/03/06 | CDE |
| 布瑞哌唑 | 黑龙江珍宝岛药业股份有限公司鸡西分公司 | Y20230000743 | A | Exact ingredient | 2026/03/09 | CDE |
| 布瑞哌唑 | 石家庄龙泽制药股份有限公司 | Y20230000669 | A | Exact ingredient | 2026/02/10 | CDE |
| 布瑞哌唑 | 华东医药（西安）博华制药有限公司 | Y20230000283 | A | Exact ingredient | 2026/06/16 | CDE |
| 布瑞哌唑 | 四川科伦药业股份有限公司 | Y20220000975 | A | Exact ingredient | 2026/08/27 | CDE |
| 布瑞哌唑 | Honour Lab Limited, Unit-Ⅲ | Y20210000838 | A | Exact ingredient | 2026/07/04 | CDE |
| 布瑞哌唑 | 山东特珐曼药业有限公司 | Y20210000803 | A | Exact ingredient | 2026/06/18 | CDE |
| 布瑞哌唑 | 湖南洞庭药业股份有限公司 | Y20200001055 | A | Exact ingredient | 2026/05/18 | CDE |
A/I are source statuses. Matching uses exact ingredients, salt-normalized names and maintained combination components, without fuzzy matching. A-status companies are deduplicated by the first registered company. Components are excluded from headline counts; the register does not identify the associated formulation.
What changed recently?
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately.
Trial registration does not mean an application will follow.
This product is outside the trial-registration backfill scope. New registrations after daily collection started remain in scope. Historical rows may also be found by another product search; neither implies complete historical coverage for this product.
NHSA edition maintained to 2026-10-23; latest successful catalogue check: 2026/11/10 07:23. NHSA records lack approval dates; only an earlier edition or observation establishes precedence.
-
2026/10/30No longer listed under review
上海复旦复华药业有限公司
CYHS2502059
Fact date: 2026/10/30 · Site observation date: 2026/10/30
Accepted: 2025/06/11
not on the CDE under-review list in this snapshot; the review / approval outcome is to be checked
View source ↗ -
2026/10/30No longer listed under review
上海复旦复华药业有限公司
CYHS2502058
Fact date: 2026/10/30 · Site observation date: 2026/10/30
Accepted: 2025/06/11
not on the CDE under-review list in this snapshot; the review / approval outcome is to be checked
View source ↗ -
2026/10/30No longer listed under review
上海复旦复华药业有限公司
CYHS2502057
Fact date: 2026/10/30 · Site observation date: 2026/10/30
Accepted: 2025/06/11
not on the CDE under-review list in this snapshot; the review / approval outcome is to be checked
View source ↗ -
2026/10/20Marketing application approved
华润双鹤湘中药业（湖南）有限公司
CYHS2502075 · 国药准字H20266323
Fact date: 2026/10/20 · Publication date: 2026/10/22 · Site observation date: 2026/11/03
The loaded NHSA codes and chemical-drug catalogue contain no evidence confirming an earlier same-name approval for this company. This does not establish the absence of an earlier approval.
View source · Table row 67 ↗ -
2026/10/20Marketing application approved
北京仁众药业有限公司
CYHS2501628 · 国药准字H20266319
Fact date: 2026/10/20 · Publication date: 2026/10/22 · Site observation date: 2026/11/03
Same-name approval records dated before this approval were found, with company roles identified below:
- Holder record / approval date · 国药准字H20265617 · 2026/08/04 · View source
-
2026/10/14Accepted
北京海步医药科技有限公司;石家庄龙泽制药股份有限公司
CYHB2601890
Fact date: 2026/10/14 · Site observation date: 2026/10/22
View source ↗ -
2026/10/14Accepted
北京海步医药科技有限公司;石家庄龙泽制药股份有限公司
CYHB2601889
Fact date: 2026/10/14 · Site observation date: 2026/10/22
View source ↗ -
2026/10/14Accepted
北京海步医药科技有限公司;石家庄龙泽制药股份有限公司
CYHB2601888
Fact date: 2026/10/14 · Site observation date: 2026/10/22
View source ↗ -
2026/08/13Accepted
-
2026/08/13Accepted
-
2026/08/13Accepted
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/10 07:27
- Chemical-drug catalogue
- Last successful update: 2026/11/10 07:23
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
- Full API register
- Last successful update: 2026/11/10 07:25
- NHSA drug codes
- Last successful update: 2026/11/05 06:45
The fully loaded edition was maintained to 2026-10-23. Publication lags maintenance: the verified 2026-10-16 edition was published on 10-28, a 12-day gap. This is not a fixed lag for every edition.
- NMPA drug delivery notices
- Last successful update: 2026/11/10 18:31
First index-page publication dates: 2026-10-26 to 2026-11-10; 0 pages pending. Covers loaded notices only, not a complete historical approval database.
- Drug Clinical Trial Registry and Information Disclosure Platform
- Last successful update: 2026/11/10 08:10 · Current coverage may be incomplete
Daily collection reads new registrations. Backfill covers registration numbers from 2025 onward (CTR2025/CTR2026), not first-publication years. States are dated observations; revisions are not tracked.
This product is outside the trial-registration backfill scope. New registrations after daily collection started remain in scope. Historical rows may also be found by another product search; neither implies complete historical coverage for this product.
Public-product searches scanned: 3/30; discovered pending details: 20. Record counts in unscanned portions remain unknown.
Filings are counted by acceptance number and filing companies by first applicant. Strengths may have separate applications. Drug names are normalized only for width and whitespace; distinct generic names, dosage forms and combinations remain separate. Unstated strengths are marked. Company counts from different sources must not be added together.
Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Free follow
Follow changes to Brexpiprazole Tablets
Up to 3 drugs per email address, in one weekly digest. Starts after email confirmation; unsubscribe at any time.
Subscriptions
Next-day facts and deliverable timelines
- One email the next day when new facts are collected for your followed products.
- Export the complete loaded event timeline for each followed product as CSV.
- Add up to 4 additional recipients, each confirmed by email.
- Increase your follow limit from 3 to 10 products.
Quarterly
US$540
Billed every three months
US$180 per month
Yearly
US$1,920
Billed every year
US$160 per month
Online subscriptions are not enabled. The form below registers interest; it does not charge or activate access.
Separate one-time purchase
US Orange Book × China records comparison
Full table and CSV export for 12 months from payment, with monthly data updates. No automatic renewal.
Subscriptions and comparison-table access are purchased separately. Neither includes the other.
US$490
One payment · 12 months of access
Online comparison-table purchase is not enabled.
Billed by Creem, our merchant of record · Terms · Refund policy